Trial intelligence / Profile preview

Population PK/PD study of single-bolus etomidate in Chinese adult surgical patients

ChiCTR-OO-13003851Phase 4Completed

Sponsor
Peking University Third Hospital
Start
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of etomidate in None, sponsored by Peking University Third Hospital. Primary endpoints: Plasma concentration of drug and Bispectral Index. Started Jun 2012; status: completed.

02

Drugs

etomidate

Beyond the preview

Go deeper on ChiCTR-OO-13003851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OO-13003851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call